Holen Sie sich die Stockscreener-App
29.91
1.48%
0.435
Handel nachbörslich:
29.92
0.01
+0.03%
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD - Investing.com
B. Riley Research Analysts Raise Earnings Estimates for CNTA - MarketBeat
OMERS ADMINISTRATION Corp Buys New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
American Century Companies Inc. Raises Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
B. Riley Analysts Boost Earnings Estimates for CNTA - Defense World
Centessa Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:CNTA) - MarketBeat
Healthy Upside Potential: Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Milestone Pharmaceuticals Inc (MIST) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Grupo Supervielle S.A. ADR (SUPV) looking to reclaim success with recent performance - Setenews
The growth track for Tron Inc (TRON) has changed recently - Setenews
Taking the lead: Argo Blockchain Plc ADR (ARBK) - Setenews
Check out these key findings about Polestar Automotive Holding UK PLC ADR (PSNY) - Setenews
There is no way Rezolve AI PLC (RZLV) can keep these numbers up - Setenews
Check out these key findings about Nova Minerals Limited ADR (NVA) - Setenews
Check Out INVO Fertility Inc (IVF)’s Trade Data Rather Than the Analysts’ Views - Setenews
An analyst sees good growth prospects for Can-Fite Biopharma Ltd ADR (CANF) - Setenews
Stocks of Klarna Group plc (KLAR) are poised to climb above their peers - Setenews
Its Stock Has Paid Off Big Time For Aptera Motors Corp - Setenews
It makes sense and dollars to buy ATA Creativity Global ADR (AACG) stock - Setenews
Check out these key findings about Hub Cyber Security Ltd (HUBC) - Setenews
A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Views of Wall Street’s Leading Experts on Liminatus Pharma Inc - Setenews
Investors in cash trouble should check out Bonk Inc (BNKK) - Setenews
Brokers Set Expectations for CNTA FY2025 Earnings - Defense World
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD - Investing.com
CNTA: Phase 2 data show best-in-class efficacy and safety for orexin agonists in sleep disorders - TradingView
The time has not yet come to remove your chips from the table: Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Campbell & CO Investment Adviser LLC Acquires New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying - The Motley Fool
Centessa Pharma chief technology officer sells $1.04 million in shares By Investing.com - Investing.com India
Centessa Pharma chief technology officer sells $1.04 million in shares - Investing.com
Centessa (CNTA) Hits All-Time High on New $287-Million Fundraising Program - Finviz
Top investors say Vistra Corp (VST) ticks everything they need - setenews.com
[8-K] Centessa Pharmaceuticals plc Reports Material Event | CNTA SEC FilingForm 8-K - Stock Titan
[424B5] Centessa Pharmaceuticals plc Prospectus Supplement (Debt Securities) - Stock Titan
AMD, Palantir among market cap stock movers on Wednesday By Investing.com - Investing.com UK
Centessa Pharmaceuticals stock hits 52-week high at $25.44 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals stock hits 52-week high at $25.44 - Investing.com
Centessa prices public offering of 11.6 million ADSs at $21.50 each By Investing.com - Investing.com South Africa
Centessa prices public offering of 11.6 million ADSs at $21.50 each - Investing.com India
Centessa Pharmaceuticals stock falls after announcing public offering - Investing.com
Centessa Pharmaceuticals stock falls after announcing public offering By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals launches public offering of ADSs By Investing.com - Investing.com India
Centessa Pharmaceuticals launches public offering of ADSs - Investing.com
Endava PLC Sponsored ADR (DAVA) Lags Q1 Earnings and Revenue Estimates - Yahoo Finance
What is Leerink Partnrs’ Estimate for CNTA FY2025 Earnings? - Defense World
Centessa Pharmaceuticals plc ADR (CNTA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
A Look at SRX Health Solutions Inc (SRXH) Shares in the Recent Past Indicates Growth - Setenews
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Down Following Weak Earnings - Defense World
Centessa Pharmaceuticals Down Over 16%, on Pace for Largest Percent Decrease Since August 2023 -- Data Talk - 富途牛牛
CNTA: ORX750 delivered robust Phase 2a results; net loss rose to $54.9M, cash runway into mid-2027 - TradingView
Mereo Biopharma Group Plc ADR (MREO) looking to reclaim success with recent performance - Setenews
Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 52-Week HighTime to Buy? - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 25.35 USD By Investing.com - Investing.com Australia
Centessa Pharmaceuticals stock hits 52-week high at 25.35 USD - Investing.com
Centessa Pharmaceuticals (CNTA) – Research Analysts’ Weekly Ratings Changes - Defense World
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):